Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

Meloxicam and rizatriptan can eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity.

EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...